Development and validation of a reversed-phase liquid chromatographic method with fluorescence detection for the study of Saquinavir pharmacokinetics in rat plasma

Shriram M. Pathak, A. Ranjith Kumar, G. Subramanian, N. Udupa

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

This research work aims to exploit the high selectivity and sensitivity of fluorescence detector to develop and validate a high performance liquid chromatography (HPLC) method having very small sampling volume, much better mass-sensitive detection limit and lower operating cost for the determination of Saquinavir (SQV), known to have low oral bioavailability, in rat plasma. Unlike the traditional methods that require at least 0.25 mL of plasma for each measurement, the present method requires only a 0.1 mL sample volume. This is very useful in reducing the blood collection from study rats, offering the possibility to make sufficient number of samples for pharmacokinetic study and minimizing the amount of blood-derived biological waste. After liquid-liquid extraction, the compounds were separated on a Vydac C18 monomeric column (250 mm × 4.6 mm i.d. × 5 μm particle size) using a mobile phase composed of acetonitrile and potassium dihydrogen phosphate buffer (45:55, v/v). Fluorescence detection was performed at 237 nm (excitation) and 380 nm (emission). Validity of the method was studied and the method was found to be precise and accurate with a linearity range from 0.005 to 1.000 μg mL-1 (r > 0.9980). The limit of detection (LOD) was found to be 0.001 μg mL-1. The intra-day and inter-day precision studies showed good reproducibility with coefficients of variation (C.V.) less than 11.4%. The developed method was applied successfully to monitor the pharmacokinetic profile following oral administration of SQV to rats.

Original languageEnglish
Pages (from-to)248-256
Number of pages9
JournalAnalytica Chimica Acta
Volume594
Issue number2
DOIs
Publication statusPublished - 02-07-2007

Fingerprint

Saquinavir
Pharmacokinetics
Rats
fluorescence
Fluorescence
Plasmas
plasma
liquid
Liquids
Blood
High performance liquid chromatography
Operating costs
Limit of Detection
Buffers
blood
Particle size
Sampling
Detectors
Liquid-Liquid Extraction
research work

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Analytical Chemistry
  • Spectroscopy
  • Environmental Chemistry

Cite this

@article{e4ee176a159042d2922298bbbbccabe3,
title = "Development and validation of a reversed-phase liquid chromatographic method with fluorescence detection for the study of Saquinavir pharmacokinetics in rat plasma",
abstract = "This research work aims to exploit the high selectivity and sensitivity of fluorescence detector to develop and validate a high performance liquid chromatography (HPLC) method having very small sampling volume, much better mass-sensitive detection limit and lower operating cost for the determination of Saquinavir (SQV), known to have low oral bioavailability, in rat plasma. Unlike the traditional methods that require at least 0.25 mL of plasma for each measurement, the present method requires only a 0.1 mL sample volume. This is very useful in reducing the blood collection from study rats, offering the possibility to make sufficient number of samples for pharmacokinetic study and minimizing the amount of blood-derived biological waste. After liquid-liquid extraction, the compounds were separated on a Vydac C18 monomeric column (250 mm × 4.6 mm i.d. × 5 μm particle size) using a mobile phase composed of acetonitrile and potassium dihydrogen phosphate buffer (45:55, v/v). Fluorescence detection was performed at 237 nm (excitation) and 380 nm (emission). Validity of the method was studied and the method was found to be precise and accurate with a linearity range from 0.005 to 1.000 μg mL-1 (r > 0.9980). The limit of detection (LOD) was found to be 0.001 μg mL-1. The intra-day and inter-day precision studies showed good reproducibility with coefficients of variation (C.V.) less than 11.4{\%}. The developed method was applied successfully to monitor the pharmacokinetic profile following oral administration of SQV to rats.",
author = "Pathak, {Shriram M.} and Kumar, {A. Ranjith} and G. Subramanian and N. Udupa",
year = "2007",
month = "7",
day = "2",
doi = "10.1016/j.aca.2007.05.028",
language = "English",
volume = "594",
pages = "248--256",
journal = "Analytica Chimica Acta",
issn = "0003-2670",
publisher = "Elsevier",
number = "2",

}

Development and validation of a reversed-phase liquid chromatographic method with fluorescence detection for the study of Saquinavir pharmacokinetics in rat plasma. / Pathak, Shriram M.; Kumar, A. Ranjith; Subramanian, G.; Udupa, N.

In: Analytica Chimica Acta, Vol. 594, No. 2, 02.07.2007, p. 248-256.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development and validation of a reversed-phase liquid chromatographic method with fluorescence detection for the study of Saquinavir pharmacokinetics in rat plasma

AU - Pathak, Shriram M.

AU - Kumar, A. Ranjith

AU - Subramanian, G.

AU - Udupa, N.

PY - 2007/7/2

Y1 - 2007/7/2

N2 - This research work aims to exploit the high selectivity and sensitivity of fluorescence detector to develop and validate a high performance liquid chromatography (HPLC) method having very small sampling volume, much better mass-sensitive detection limit and lower operating cost for the determination of Saquinavir (SQV), known to have low oral bioavailability, in rat plasma. Unlike the traditional methods that require at least 0.25 mL of plasma for each measurement, the present method requires only a 0.1 mL sample volume. This is very useful in reducing the blood collection from study rats, offering the possibility to make sufficient number of samples for pharmacokinetic study and minimizing the amount of blood-derived biological waste. After liquid-liquid extraction, the compounds were separated on a Vydac C18 monomeric column (250 mm × 4.6 mm i.d. × 5 μm particle size) using a mobile phase composed of acetonitrile and potassium dihydrogen phosphate buffer (45:55, v/v). Fluorescence detection was performed at 237 nm (excitation) and 380 nm (emission). Validity of the method was studied and the method was found to be precise and accurate with a linearity range from 0.005 to 1.000 μg mL-1 (r > 0.9980). The limit of detection (LOD) was found to be 0.001 μg mL-1. The intra-day and inter-day precision studies showed good reproducibility with coefficients of variation (C.V.) less than 11.4%. The developed method was applied successfully to monitor the pharmacokinetic profile following oral administration of SQV to rats.

AB - This research work aims to exploit the high selectivity and sensitivity of fluorescence detector to develop and validate a high performance liquid chromatography (HPLC) method having very small sampling volume, much better mass-sensitive detection limit and lower operating cost for the determination of Saquinavir (SQV), known to have low oral bioavailability, in rat plasma. Unlike the traditional methods that require at least 0.25 mL of plasma for each measurement, the present method requires only a 0.1 mL sample volume. This is very useful in reducing the blood collection from study rats, offering the possibility to make sufficient number of samples for pharmacokinetic study and minimizing the amount of blood-derived biological waste. After liquid-liquid extraction, the compounds were separated on a Vydac C18 monomeric column (250 mm × 4.6 mm i.d. × 5 μm particle size) using a mobile phase composed of acetonitrile and potassium dihydrogen phosphate buffer (45:55, v/v). Fluorescence detection was performed at 237 nm (excitation) and 380 nm (emission). Validity of the method was studied and the method was found to be precise and accurate with a linearity range from 0.005 to 1.000 μg mL-1 (r > 0.9980). The limit of detection (LOD) was found to be 0.001 μg mL-1. The intra-day and inter-day precision studies showed good reproducibility with coefficients of variation (C.V.) less than 11.4%. The developed method was applied successfully to monitor the pharmacokinetic profile following oral administration of SQV to rats.

UR - http://www.scopus.com/inward/record.url?scp=34250655363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250655363&partnerID=8YFLogxK

U2 - 10.1016/j.aca.2007.05.028

DO - 10.1016/j.aca.2007.05.028

M3 - Article

VL - 594

SP - 248

EP - 256

JO - Analytica Chimica Acta

JF - Analytica Chimica Acta

SN - 0003-2670

IS - 2

ER -